Showing results (71-80 of 172) with videos related to

Sort By:
Pageof 18
Cardiovascular Drugs and Therapy|August 1, 1995
Digoxin and mortality in survivors of acute myocardial infarction: observations in patients at low and intermediate risk. The SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine TrialJ Leor, U Goldbourt, S Behar, et al.
Journal of Virology|November 9, 2000
Cellular targets of functional and dysfunctional mutants of tobacco mosaic virus movement protein fused to green fluorescent proteinV Boyko, J van der Laak, J Ferralli, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020
[Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab]O V Boyko, I I Choroshilova, S V Petrov, et al.
Journal of Clinical Epidemiology|October 1, 1995
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine TrialE Disegni, U Goldbourt, H Reicher-Reiss, et al.
Cardiovascular Drugs and Therapy|October 1, 1995
Digoxin and increased mortality among patients recovering from acute myocardial infarction: importance of digoxin dose. The SPRINT Study GroupJ Leor, U Goldbourt, B Rabinowitz, et al.
Scientific Reports|February 6, 2019
Reference assembly and gene expression analysis of Apostichopus japonicus larval developmentAlexey V Boyko, Alexander S Girich, Marina G Eliseikina, et al.
Klinichna Khirurhiia|June 30, 2017
[[Treatment and prophylaxis of complications of the sternotomy access in thoracic operations].]V V Boyko, Yu V Ivanova, D V Vasilyev, et al.
The American Journal of Cardiology|June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study GroupM Haim, A Shotan, V Boyko, et al.
Journal of the American College of Cardiology|April 3, 1998
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research GroupS Braun, V Boyko, S Behar, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|August 13, 2021
[A rare clinical case of comorbidity of early-onset Parkinson's disease and remitting multiple sclerosis]E A Katunina, O V Boyko, N N Shipilova, et al.
Pageof 18